KMKatrina Morris

Katrina Morris

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katrina Morris has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reproductive decision‐making experiences of Australian adults with neurofibromatosis type 1 and schwannomatosis

    by Tina Gonzalez, Alison McLean, Jane Fleming, Katrina Morris, Melissa Pacque, Caitlin Forwood, Claire Wong, Sue‐Faye Siow, Sarah Barter, Kristi J. Jones, et al.

    Individuals with neurofibromatosis type 1 and schwannomatosis (NF) often face difficult reproductive choices when family planning; however, their experiences and the barriers and enablers to reproductive decision‐making are poorly understood. The purpose of this study was to explore the opinions and experiences of individuals with NF in Australia and inform the development of practice recommendations and resources. Focus groups with adults with NF were conducted using a semi‐structured interview schedule developed by the research team. Partners were also invited. The focus groups were recorded, de‐identified, transcribed, and analyzed using codebook thematic analysis. Three focus groups were conducted with 17 participants (12 = NF1, 4 = NF2‐related schwannomatosis [NF2‐SWN] and one partner). Three themes were identified: (1) Barriers and enablers; (2) Contemplating the options; and (3) Education and support needs. Barriers to reproductive decision‐making included: difficulty accessing healthcare services to discuss reproductive planning; a lack of access to reliable information sources and support; and, in some cases, the financial cost of assistive reproductive technology. Conversely, positive healthcare experiences and support systems enabled reproductive choices. Participants reported many factors that contributed to their reproductive decisions, including: their personal experience of their condition; concern about their future health and that of an affected child; the impact of pregnancy on their health; and the opinion of healthcare providers, family, and friends. Many participants reported mental health difficulties related to their condition and additional stressors related to the reproductive journey. Participants' recommendations included increased access to healthcare services to discuss reproductive options, the development of comprehensive information resources, and improved psychological and peer support for individuals with NF considering family planning and, where relevant, their partners. In conclusion, people with NF and their partners identify a need for improved awareness of NF among healthcare professionals and increased access to appropriate services, information, and support to facilitate informed reproductive decision‐making.


  • Comparing the sensitivity of linear and volumetric MRI measurements to detect changes in the size of vestibular schwannomas in patients with neurofibromatosis type 2 on bevacizumab treatment

    by Katrina A Morris, Allyson Parry, Pieter M Pretorius

    Objective:To compare the sensitivity of linear and volumetric measurements on MRI in detecting schwannoma progression in patients with neurofibromatosis type 2 on bevacizumab treatment as well as the extent to which this depends on the size of the tumour.Methods:We compared retrospectively, changes in linear tumour dimensions at a range of thresholds to volumetric tumour measurements performed using Brainlab iPlan software and classified for tumour progression according to the REiNS criteria.Results:Assessment of 61 schwannomas in 46 patients with a median follow-up of 20 months (range 3 - 43 months) was performed. There was a mean of 7 time points per tumour (range 2 - 12). Using the volumetric REiNS criteria as a gold standard, a sensitivity of 86% was achieved for linear measurement using a 2mm threshold to define progression.Conclusions:We propose that a change in linear measurement by 2mm (particularly in tumours with starting diameters 20 - 30mm, the majority of this cohort) could be used as a filte...


  • Treatment Update in Multiple Sclerosis

    by Katrina Morris, Con Yiannikas

    Multiple sclerosis is the most common cause of disability in young people in the Western world. Reduced life expectancy and worsening quality of life due to increasing disability later in the disease course have significant personal and societal costs. Changes in treatment strategies and newly available treatments hope to improve the outlook for our often young patients. This paper details currently available treatments and some that are expected to reach the market shortly.